Table 3.
Multivariate analysis to find the adjusted association between serum CRP and anti-coagulation therapy method, adjusted for other determinants
| Coefficient (β) | Coefficient (β) | SE for β | P value |
|---|---|---|---|
| Treatment (Dabigatran) | -8.206 | 2.5739 | 0.001 |
| Female sex | 3.800 | 4.2175 | 0.368 |
| Age | .005 | .0511 | 0.921 |
| Heart Failure | -13.885 | 10.4636 | 0.185 |
| Hypertension | 4.094 | 12.9830 | 0.752 |
| Diabetes | 14.603 | 2.5893 | <0.001 |
| Coronary Artery Disease | -.736 | 7.8232 | 0.925 |
| Chronic renal insufficiency | 8.504 | 11.0892 | 0.443 |
| Aspirin | .267 | 2.7622 | 0.923 |
| ACE inhibitors | -6.393 | 9.0849 | 0.482 |
| Beta blockers | 4.790 | 6.6190 | 0.469 |
| Statins | -4.494 | 4.2877 | 0.481 |
| Calcium Channel Blockers | -5.722 | 5.6481 | 0.311 |